No new info from what I heard on the podcast. Emphasis is mine.
Nothing about manufacturing or Lonza.
Things SI said that stood out
- ARDS trial total patient recruitment of about 300 expected to take in 3-4 months
- In the meantime we will have early interim analyses released that hopefully will show that the sort of efficacy in the pilot study will be replicated
- Number of trial readouts coming this year
- First product about to be launched for gvhd
- Hope the covid product will be the second
MSB - Most exciting 6 months, page-366
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.44 |
Change
-0.010(0.69%) |
Mkt cap ! $1.644B | |||
| Open | High | Low | Value | Volume |
| $1.50 | $1.50 | $1.43 | $4.048M | 2.778M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 26808 | $1.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 16001 | 1 |
View Market Depth
| Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |